He succeeds Nancy Buese, who “by mutual agreement with the company” will no longer serve as CFO. Buese will move to a ...
QCR Holdings, Inc. (NASDAQ: QCRH) ("QCR Holdings” or the "Company”), today announced that, effective immediately following ...
After leaving the FDA, where she served as director of the Center for Drug Evaluation and Research, Patrizia Cavazzoni, M.D., ...
MANCHESTER, N.H., Feb. 24, 2025 (GLOBE NEWSWIRE) -- Allegro MicroSystems, Inc. ("Allegro”) (Nasdaq: ALGM) a global leader in ...
“I’m thrilled to join Navigator at such an exciting and pivotal time for the Company,” said Tosh Butt, Chief Executive Officer of Navigator Medicines. “We’re fortunate to have one of the ...
He has served as KALA’s President since December 2021 and as KALA’s Chief Operating Officer since November 2017. Prior to joining the company, Todd served as Executive Vice President and Chief ...
Tobolski, PhD, as Chief Executive Officer effective as of the Company's Annual Shareholders' meeting on May 13, 2025. Dr. Tobolski will succeed Gary Fields, who will remain a member of the Board ...